Recent advances in CO2 bubble-generating carrier systems for localized controlled release.

This article reviews recent progress in the development of carbon dioxide (CO2) bubble-generating drug carriers, including their designs and operating mechanisms; these carriers constitute an advanced class of stimuli-responsive delivery systems with considerable potential. The drug carriers contain stimuli-responsive agents, which are stable before they reach the target location, but enable rapid drug release that is triggered by the generation of CO2 bubbles, which are chemically inert, under certain stimuli. These CO2 bubble-generating carrier systems can be used to accumulate locally a delivered drug at the diseased tissue, while reducing side effects on the normal tissue, improving their therapeutic effectiveness. Since the generated CO2 bubbles are hyperechogenic, they may also be used as an ultrasound contrast agent in elucidating the status of the carriers and providing real-time diagnostic images. Perspectives of the future of applications of gases with therapeutic effects, such as nitric oxide (NO), carbon monoxide (CO), and hydrogen sulfide (H2S), in such bubble-generating carrier systems, are also briefly discussed.

Safety and efficacy of self-assembling bubble carriers stabilized with sodium dodecyl sulfate for oral delivery of therapeutic proteins.

Sodium dodecyl sulfate (SDS) is generally regarded as a potent permeability enhancer in oral formulations; however, one concern related to the use of any permeation enhancer is its possible absorption of unwanted toxins during the period of epithelial permeability enhancement. In this work, the safety and efficacy of an SDS-containing bubble carrier system that is developed from an orally administered enteric-coated capsule are evaluated. The bubble carriers comprise diethylene triamine pentaacetic acid (DTPA) dianhydride, sodium bicarbonate (SBC), SDS, and insulin. Upon exposure to the intestinal fluid, DTPA dianhydride hydrolyzes to yield acids, and SBC rapidly reacts with these acids to generate CO2, producing bubble carriers, each containing a self-assembling water film. The hydrophilic insulin is entrapped in the self-assembled water film, which is stabilized by SDS. The SDS in the bubble carrier system can act as a dissolution enhancer in the dispersion of insulin molecules, as a surfactant that stabilizes the bubble carriers, as a protease inhibitor that protects the protein drug, and as a permeation enhancer that augments its oral bioavailability. Hence, a significant increase in the plasma insulin level and an excellent blood glucose-lowering response in diabetic rats are effectively achieved. Moreover, the enhancement of epithelial permeation by this SDS-containing formulation does not promote the absorption of intestinal endotoxins. The above facts indicate that the bubble carrier system that is stabilized by SDS can be used as a safe and potent carrier in the oral delivery of therapeutic proteins.

Superconcentrated electrolytes for a high-voltage lithium-ion battery.

Finding a viable electrolyte for next-generation 5 V-class lithium-ion batteries is of primary importance. A long-standing obstacle has been metal-ion dissolution at high voltages. The LiPF6 salt in conventional electrolytes is chemically unstable, which accelerates transition metal dissolution of the electrode material, yet beneficially suppresses oxidative dissolution of the aluminium current collector; replacing LiPF6 with more stable lithium salts may diminish transition metal dissolution but unfortunately encounters severe aluminium oxidation. Here we report an electrolyte design that can solve this dilemma. By mixing a stable lithium salt LiN(SO2F)2 with dimethyl carbonate solvent at extremely high concentrations, we obtain an unusual liquid showing a three-dimensional network of anions and solvent molecules that coordinate strongly to Li(+) ions. This simple formulation of superconcentrated LiN(SO2F)2/dimethyl carbonate electrolyte inhibits the dissolution of both aluminium and transition metal at around 5 V, and realizes a high-voltage LiNi0.5Mn1.5O4/graphite battery that exhibits excellent cycling durability, high rate capability and enhanced safety.

General observation of lithium intercalation into graphite in ethylene-carbonate-free superconcentrated electrolytes.

Lithium-ion batteries have exclusively employed an ethylene carbonate (EC)-based electrolyte to ensure the reversibility of the graphite negative electrode reaction. Because of the limitation of electrolyte compositions, there has been no remarkable progress in commercial lithium-ion batteries despite active research on positive electrode materials. Herein, we present a salt-superconcentrating strategy as a simple and effective method of universalizing a graphite negative electrode reaction in various organic solvents. A dilute electrolyte (e.g., 1 mol dm(-3)) of sulfoxide, ether, and sulfone results in solvent cointercalation and/or severe electrolyte decomposition at a graphite electrode, whereas their superconcentrated electrolyte (e.g., >3 mol dm(-3)) allows for highly reversible lithium intercalation into graphite. We have found a unique coordination structure in the superconcentrated solution and an anion-based inorganic SEI film on the cycled graphite electrode, which would be the origin of the reversible graphite negative electrode reaction without EC. Our salt-superconcentrating strategy, expanding the graphite negative electrode reaction in various organic solvents other than EC, will contribute to the development of advanced lithium-ion batteries with high-voltage and fast-charging characters based on new EC-free functional electrolytes.